Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04883502 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of the Role of the Induced Membrane in the Reconstruction of Bone Loss in the Limbs

Study acronym: MEMBRAN
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Re-verified, no change to tracked fieldsv5
  2. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2021 to Oct 29, 2021
    • Site details revised at 2 of 2 sites
    v4
  3. Minor Primary and study completion dates: Mar 2028 to Apr 2028
    • Start date: Sep 2021 to Oct 2021
    v3
  4. Notable Start date: May 2021 to Sep 2021
    • Primary and study completion dates: Nov 2027 to Mar 2028
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Masquelet's induced membrane technique is a two-stage reconstructive surgery for severe bone fractures commonly used by military orthopedists. The particularity of this technique relies on the synthesis of a biological membrane induced by the transient implantation of a surgical cement (= 1st stage surgery). The presence of the induced membrane in the reconstruction space defines a microenvironment or "biological chamber" favourable to osteogenesis, positively influencing the repair of the lesion after implantation of an autologous bone graft (= 2nd stage of surgery). In view of the excellent clinical results obtained with this procedure, the Masquelet technique has gradually become a reference treatment in the field of orthopedic and trauma surgery. However, orthopedic surgeons sometimes observe failures in bone consolidation. To our knowledge, the role played by induced membrane in these therapeutic failures has never been studied.
Trial Details
NCT Number NCT04883502
Lead Sponsor Direction Centrale du Service de Santé des Armées
Conditions
(from sponsor)
Bone Loss
Related terms Bone Diseases, Metabolic
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov